News
Where Fortrea Holdings Stands With Analysts
22 Mar 24
Analyst Ratings
Baird Initiates Coverage On Fortrea Holdings with Neutral Rating, Announces Price Target of $43
22 Mar 24
News, Price Target, Initiation, Analyst Ratings
B of A Securities Maintains Underperform on Fortrea Holdings, Raises Price Target to $33
12 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Monday's Pre-Market Session
11 Mar 24
Movers
Fortrea Holdings Q4 Adjusted EPS $0.19 Misses $0.24 Estimate, Sales $775.40M Miss $776.06M Estimate
11 Mar 24
Earnings, News
Fortrea Will Divest Assets Relating To Its Enabling Services Segment, Namely Its Endpoint Clinical And Fortrea Patient Access Businesses, To Arsenal Capital Partners For $345M
11 Mar 24
M&A, News, Health Care, General
Earnings Scheduled For March 11, 2024
11 Mar 24
Earnings
Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday
11 Mar 24
Earnings, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
12 Health Care Stocks Moving In Friday's After-Market Session
8 Mar 24
Movers
Key Takeaways From Fortrea Holdings Analyst Ratings
6 Mar 24
Analyst Ratings
Deutsche Bank Initiates Coverage On Fortrea Holdings with Hold Rating, Announces Price Target of $36
6 Mar 24
News, Price Target, Initiation, Analyst Ratings
Fortrea Increases Patient Access Capabilities And Cold Chain Expertise With FortreaRx Expansion
20 Feb 24
Biotech, News, General
Press releases
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
6 May 24
Press Releases
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
11 Apr 24
Press Releases
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
11 Mar 24
Earnings, Press Releases
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
11 Mar 24
News, Contracts, Press Releases